The MicroRNA-21/PTEN Pathway Regulates the Sensitivity of HER2-Positive Gastric Cancer Cells to Trastuzumab
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The MicroRNA-21/PTEN Pathway Regulates the Sensitivity of HER2-Positive Gastric Cancer Cells to Trastuzumab
Authors
Keywords
Gastric Cancer, Trastuzumab, Gastric Cancer Cell, Gastric Cancer Cell Line, PTEN Expression
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 21, Issue 1, Pages 343-350
Publisher
Springer Nature
Online
2013-10-24
DOI
10.1245/s10434-013-3325-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells
- (2014) Mei Mei et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Catecholamine-Induced 2-Adrenergic Receptor Activation Mediates Desensitization of Gastric Cancer Cells to Trastuzumab by Upregulating MUC4 Expression
- (2013) M. Shi et al. JOURNAL OF IMMUNOLOGY
- miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN
- (2013) Shou-mei Yang et al. TOXICOLOGY
- Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis
- (2012) Y. Y. Janjigian et al. ANNALS OF ONCOLOGY
- Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma
- (2012) Junji Kurashige et al. JOURNAL OF SURGICAL ONCOLOGY
- microRNAs in cancer management
- (2012) Yi W Kong et al. LANCET ONCOLOGY
- MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab
- (2011) N. Nishida et al. CLINICAL CANCER RESEARCH
- Up-regulation ofmiR-21Mediates Resistance to Trastuzumab Therapy for Breast Cancer
- (2011) Chang Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
- (2011) Maria D. Begnami et al. JOURNAL OF CLINICAL ONCOLOGY
- Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells
- (2010) Guo-hai Shi et al. ACTA PHARMACOLOGICA SINICA
- PTEN, PIK3CA, p-AKT, and p-p70S6K Status
- (2010) Francisco J. Esteva et al. AMERICAN JOURNAL OF PATHOLOGY
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF
- (2010) Shadan Ali et al. CANCER RESEARCH
- microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network
- (2010) Liming Zhang et al. CARCINOGENESIS
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
- (2009) J. Ribas et al. CANCER RESEARCH
- microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells
- (2009) P. Wang et al. CANCER RESEARCH
- MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma
- (2009) Y. Hiyoshi et al. CLINICAL CANCER RESEARCH
- The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo
- (2009) J. T. Huse et al. GENES & DEVELOPMENT
- Differential Expression of PTEN-Targeting MicroRNAs miR-19a and miR-21 in Cowden Syndrome
- (2008) Marcus G. Pezzolesi et al. AMERICAN JOURNAL OF HUMAN GENETICS
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival
- (2008) J. Jiang et al. CLINICAL CANCER RESEARCH
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
- miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
- (2008) Zhiyu Zhang et al. LABORATORY INVESTIGATION
- Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
- (2008) Changchun Xiao et al. NATURE IMMUNOLOGY
- Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
- (2008) Gabriella Mariani et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started